UBS Group’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.9M Buy
1,355,289
+172,331
+15% +$679K ﹤0.01% 4327
2025
Q4
$4.81M Sell
1,182,958
-261,028
-18% -$1.17M ﹤0.01% 4068
2025
Q3
$5.13M Buy
1,443,986
+298,551
+26% +$1.08M ﹤0.01% 4010
2025
Q2
$3.13M Buy
1,145,435
+416,613
+57% +$860K ﹤0.01% 4353
2025
Q1
$1.22M Buy
728,822
+279,969
+62% +$783K ﹤0.01% 5110
2024
Q4
$732K Buy
448,853
+144,115
+47% +$430K ﹤0.01% 5565
2024
Q3
$1.27M Buy
304,738
+64,100
+27% +$337K ﹤0.01% 4430
2024
Q2
$1.31M Sell
240,638
-133,089
-36% -$1.06M ﹤0.01% 4163
2024
Q1
$3.74M Buy
373,727
+66,307
+22% +$497K ﹤0.01% 3284
2023
Q4
$1.25M Buy
307,420
+199,080
+184% +$733K ﹤0.01% 4299
2023
Q3
$419K Sell
108,340
-39,050
-26% -$210K ﹤0.01% 4793
2023
Q2
$878K Sell
147,390
-15,653
-10% -$90.2K ﹤0.01% 4361
2023
Q1
$533K Sell
163,043
-178,831
-52% -$715K ﹤0.01% 4634
2022
Q4
$1.35M Buy
341,874
+282,041
+471% +$1.38M ﹤0.01% 3780
2022
Q3
$359K Sell
59,833
-167,166
-74% -$1.21M ﹤0.01% 4622
2022
Q2
$1.46M Sell
226,999
-80,812
-26% -$515K ﹤0.01% 3403
2022
Q1
$2.54M Buy
307,811
+196,844
+177% +$1.59M ﹤0.01% 3202
2021
Q4
$1.72M Buy
110,967
+55,962
+102% +$1.08M ﹤0.01% 3873
2021
Q3
$1.24M Buy
55,005
+46,367
+537% +$973K ﹤0.01% 4000
2021
Q2
$170K Buy
8,638
+4,086
+90% +$92.6K ﹤0.01% 5475
2021
Q1
$153K Buy
+4,552
New +$148K ﹤0.01% 5650

Other funds holding SANA